Avadel Pharmaceuticals (AVDL) Revenue: 2009-2020
Historic Revenue for Avadel Pharmaceuticals (AVDL) over the last 11 years, with Dec 2020 value amounting to -$3.3 million.
- Avadel Pharmaceuticals' Revenue fell 130.09% to -$3.3 million in Q4 2020 from the same period last year, while for Dec 2020 it was $15.8 million, marking a year-over-year decrease of 73.37%. This contributed to the annual value of -$10.8 million for FY2024, which is N/A change from last year.
- Latest data reveals that Avadel Pharmaceuticals reported Revenue of -$3.3 million as of Q4 2020, which was down 1.50% from -$3.3 million recorded in Q3 2020.
- Avadel Pharmaceuticals' 5-year Revenue high stood at $52.5 million for Q1 2017, and its period low was -$3.3 million during Q4 2020.
- Over the past 3 years, Avadel Pharmaceuticals' median Revenue value was $15.3 million (recorded in 2019), while the average stood at $14.9 million.
- Its Revenue has fluctuated over the past 5 years, first spiked by 18,008.00% in 2016, then slumped by 130.09% in 2020.
- Over the past 5 years, Avadel Pharmaceuticals' Revenue (Quarterly) stood at $43.1 million in 2016, then fell by 19.34% to $34.8 million in 2017, then tumbled by 39.80% to $20.9 million in 2018, then tumbled by 47.44% to $11.0 million in 2019, then tumbled by 130.09% to -$3.3 million in 2020.
- Its Revenue was -$3.3 million in Q4 2020, compared to -$3.3 million in Q3 2020 and $10.1 million in Q2 2020.